Episode 1: Inflammation and Heart Attacks: A New Frontier in Prevention with LODOCO Podcast By  cover art

Episode 1: Inflammation and Heart Attacks: A New Frontier in Prevention with LODOCO

Episode 1: Inflammation and Heart Attacks: A New Frontier in Prevention with LODOCO

Listen for free

View show details

About this listen

In this episode of Industry Innovations, host Dr. Peter Jones is joined by Dr. Guy Mintz to explore an exciting advancement in cardiovascular care: LODOCO, a low-dose colchicine developed by Agepha Pharma. Backed by robust clinical trial data, LODOCO is an FDA-approved therapy targeting inflammation as a novel approach to reducing the risk of heart attacks.

Learn how inflammation contributes to cardiovascular events and why this groundbreaking therapy is redefining prevention strategies. Dr. Mintz discusses the science, the data, and the potential impact of LODOCO on clinical practice, offering valuable insights for clinicians committed to improving patient outcomes.

Sponsored by Agepha Pharma

No reviews yet